D.J. St. Germain’s Quest Diagnostics DGX Stock Holding History

D.J. St. Germain’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.69K	Hold	41	–	–	﹤0.01%	702
2026 Q1	$8.04K	Hold	41	–	–	﹤0.01%	690
2025 Q4	$7.12K	Hold	41	–	–	﹤0.01%	703
2025 Q3	$7.81K	Hold	41	–	–	﹤0.01%	680
2025 Q2	$7.37K	Sell	41 -34	-45%	-$5.91K	﹤0.01%	696
2025 Q1	$12.7K	Buy	75 +34	+83%	+$5.58K	﹤0.01%	540
2024 Q4	$6.18K	Hold	41	–	–	﹤0.01%	648
2024 Q3	$6.37K	Hold	41	–	–	﹤0.01%	593
2024 Q2	$5.61K	Hold	41	–	–	﹤0.01%	603
2024 Q1	$5.46K	Hold	41	–	–	﹤0.01%	601
2023 Q4	$5.65K	Hold	41	–	–	﹤0.01%	605
2023 Q3	$5K	Hold	41	–	–	﹤0.01%	582
2023 Q2	$5.76K	Buy	+41	New	+$5.65K	﹤0.01%	578

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

D.J. St. Germain's DGX Position: Q2 2026 in Review

D.J. St. Germain held its Quest Diagnostics (DGX) position steady in Q2 2026 at 41 shares worth $8.69K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

D.J. St. Germain first reported a position in DGX in Q2 2023 and has held it in 13 quarters since. The position peaked at $12.7K in Q1 2025. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

D.J. St. Germain held 41 shares of Quest Diagnostics worth $8.69K as of Q2 2026.
D.J. St. Germain left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #702 holding.
D.J. St. Germain first reported a position in Quest Diagnostics in Q2 2023 and has held it in 13 quarters since.
D.J. St. Germain's Quest Diagnostics position peaked at $12.7K in Q1 2025.
1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.